Health & Fitness
Health and Fitness
Health and Fitness
Sun, March 25, 2012Sat, March 24, 2012Fri, March 23, 2012Thu, March 22, 2012Wed, March 21, 2012Tue, March 20, 2012Mon, March 19, 2012Sun, March 18, 2012Fri, March 16, 2012Thu, March 15, 2012Wed, March 14, 2012Tue, March 13, 2012Mon, March 12, 2012Analytical Reports on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Drug Manufacturers Flexing Pipeline
Published in Health and Fitness on Friday, March 16th 2012 at 5:31 GMT by Market Wire
March 16, 2012 08:25 ET
Analytical Reports on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Drug Manufacturers Flexing Pipelines, Releasing Generics
NEW YORK, NY--(Marketwire - Mar 16, 2012) - [ www.SignalWatcher.com ] provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on Teva Pharmaceutical Industries Limited (
As patents for blockbuster drugs continue to expire, companies in the Drug Manufacturers - Other industry have been working hard to bring the next big product to market. Major players in the industry have been working on treatments for a variety of ailments, including major depressive disorder, cancer and a number of others.
[ www.SignalWatcher.com ] brings investors free classic analysis on Teva Pharmaceutical Industries Limited, Forest Laboratories Inc. and other companies within the Drug Manufacturers - Other industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at [ http://signalwatcher.com/EmailSignup.php ].
Research and development costs remain high for the industry and there are no guarantees that there will be any payoff. However, several companies have been making solid progress. Forest Laboratories Inc. together with Pierre Fabre Medicament recently stated they had successfully completed two positive Phase III studies of their levomilnacipran offing, an investigational agent used for the treatment of major depressive disorder in adults. [ www.SignalWatcher.com ] gives traders a unique insight about Forest Laboratories Inc. by registering now at [ http://signalwatcher.com/FRX/March162012.php ].
On the other hand, Teva Pharmaceuticals Industries Limited has also been busy recently, with its Teva UK subsidiary announcing that it has released a generic alternative to GlaxoSmithKline UK's Naramig®, which is used in the treatment of migraine headaches. [ www.SignalWatcher.com ] gives traders a unique insight about Teva Pharmaceutical Industries Limited by registering now at [ http://signalwatcher.com/TEVA/March162012.php ].
About Signal Watch
Signal Watch's #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.
Read our disclaimer by clicking on the following link [ http://www.signalwatcher.com/disclaimers.php ].
